March 22
- March 25
KCAS Bio will be exhibiting at the Society of Toxicology (SOT) Annual Meeting and ToxExpo, taking place in San Diego, California on March 22-25, 2026. As one of the largest gatherings of toxicologists and life sciences professionals, this event offers a unique platform to connect with leaders in toxicology and…
March 19
- March 20
KCAS Bio will be a sponsor at the Boston Society Gene and Cell Therapy Conference, taking place in Cambridge, Massachusetts, on March 19-20, 2026. This event gathers leading experts, innovators, and researchers to explore the latest advancements in gene and cell therapy. Advancing Gene and Cell Therapy with Bioanalytical Expertise…
March 16
- March 19
KCAS Bio will be attending the 17th Open Scientific EIP (European Immunogenicity Platform) Symposium, taking place in Lisbon, Portugal, from March 16-19, 2026. This event brings together global leaders in immunogenicity to share insights, exchange ideas, and drive innovation in the development of biologics and biotherapeutics. We are excited to…
April 13
- April 17
KCAS Bio is proud to announce our participation in the 20th Annual Workshops on Recent Issues in Bioanalysis (WRIB), taking place from April 13th to April 17th, 2026, in Dallas, TX. As a leading event for the bioanalytical community, WRIB brings together global experts to share innovative solutions, discuss emerging…
Blogs
Global drug development now operates across borders by default. Pharmaceutical and biotech R&D routinely spans multiple countries, driven by competitive timelines, access to patients, and the need for specialized expertise. Governments have responded by actively courting development programs through incentives, talent investment, and streamlined infrastructure. Australia remains a strong example,…
Podcasts
John and Dom introduce guest Brad Nawa (Alamar Biosciences) to explain the NULISA™ platform, an ultra-sensitive platform for protein quantitation that aims to outperform earlier “ultra-sensitive” tools that often didn’t translate well in practice. Brad notes the platform is still antibody/content-driven, but differentiates itself by reducing background through a dual-capture…
Podcasts
This pre-holiday episode of “The Conversational Flow” dives into how scientific understanding evolves over time, using immunology as a case study to highlight how often researchers underestimate what they don’t yet know. Adam and Brian reflect on historical quotes from medicine and science that confidently declared fields “complete,” only to…
News
KCAS Bio has officially received the Scientist.com Supplier Recognition Award for outstanding performance in offering drug discovery research services on their R&D sourcing platform for 2025. KCAS Bio’s contibutions were recognized to enhance research efficiency worldwide. This award was evaluated based on responsiveness – the time it takes to…
Blogs
Originally developed to monitor B cells producing antigen- or pathogen-specific antibodies, the ELISpot assay is widely used for evaluating vaccine-induced wanted immunogenicity. However, thanks to its high sensitivity, it is also a valuable tool for investigating unwanted immunogenicity, expanding its applications beyond traditional vaccine research. Early Applications in Preclinical…
webinars
This webinar is a collaboration between Sciex and KCAS Bio. Exploring cutting-edge methods for analyzing oligonucleotides in biological matrices. Oligonucleotide therapeutics have gained recent popularity given their vast applications in genetic disorders, cancers and infectious diseases. There are many challenges when developing bioanalytical methods for the quantitation of oligonucleotides, including…
Posters & Papers
This presentation, given at the 2025 AAPS PharmSci Conference by Dawn Dufield, PhD, Scientific Officer of Mass Spectrometry at KCAS Bio, reviews Bioanalytical Strategies for Therapeutic Drugs and Their Conjugates (ADCs, Oligos, siRNA, ASOs and AOCs/ARCs) by QqQ/HRMS. ADC_ARC Conjugates Presentation AAPS 2025_KCAS Bio…
Blogs
Cell therapy clinical trials present unique challenges when it comes to monitoring both pharmacodynamic (PD) and persistence endpoints. Unlike traditional small molecules or biologics, cell therapies involve living products that interact dynamically with the patient’s immune system. Understanding how these cells persist, expand, and function in vivo is critical for…